◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Gunpoint Exploration Ltd.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00 --
Operating Revenue 0.00 0.00 0.00 0.00 0.00 --
Selling General And Administration 73,000 141,000 94,000 24,000 129,000 --
General And Administrative Expense 73,000 141,000 94,000 24,000 129,000 --
Other Operating Expenses 4,000 34,000 25,000 47,000 64,000 --
Operating Expense 77,000 175,000 119,000 71,000 193,000 --
Operating Income -77,000 -175,000 -119,000 -71,000 -193,000 --
EBIT 46,000 -76,000 -119,000 -60,000 -90,000 --
Interest Expense 1,000 0.00 -- 0.00 0.00 1,000
Interest Expense Non Operating 1,000 0.00 -- 0.00 0.00 1,000
Net Interest Income -1,000 0.00 -- 0.00 0.00 -1,000
Other Income Expense 123,000 99,000 98,000 11,000 103,000 --
Other Non Operating Income Expenses 1,000 2,000 2,000 5,000 8,000 --
Gain On Sale Of Security 122,000 97,000 96,000 31,000 95,000 --
Pretax Income 45,000 -76,000 -21,000 -60,000 -90,000 --
Tax Effect Of Unusual Items 18,300 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation 45,000 -76,000 -21,000 -60,000 -90,000 --
Net Income From Continuing Operation Net Minority Interest 45,000 -76,000 -21,000 -60,000 -90,000 --
Net Income Including Noncontrolling Interests 45,000 -76,000 -21,000 -60,000 -90,000 --
Net Income Common Stockholders 45,000 -76,000 -21,000 -60,000 -90,000 --
Net Income 45,000 -76,000 -21,000 -60,000 -90,000 --
EBITDA 46,000 -76,000 -119,000 -60,000 -90,000 --
Normalized EBITDA -76,000 -173,000 -215,000 -66,000 -185,000 --
Basic EPS 0.00 0.00 0.00 -- -0.01 -0.01
Diluted EPS 0.00 0.00 0.00 -- -0.01 -0.01
Basic Average Shares 51.3M 51.3M 51.3M -- 50.9M 50.9M
Diluted Average Shares 51.3M 51.3M 51.3M -- 50.9M 50.9M
Total Unusual Items 122,000 97,000 96,000 6,000 95,000 --
Total Unusual Items Excluding Goodwill 122,000 97,000 96,000 6,000 95,000 --
Tax Rate For Calcs 0.15 0.00 0.00 0.00 0.00 --
Normalized Income -58,700 -173,000 -117,000 -66,000 -185,000 --
Diluted NI Availto Com Stockholders 45,000 -76,000 -21,000 -60,000 -90,000 --
Net Income Continuous Operations 45,000 -76,000 -21,000 -60,000 -90,000 --
Net Non Operating Interest Income Expense -1,000 0.00 -- 0.00 0.00 -1,000
Other Gand A 50,000 119,000 72,000 130,000 64,000 --
Salaries And Wages 23,000 22,000 22,000 -106,000 65,000 --
Total Expenses 77,000 175,000 119,000 71,000 193,000 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 755,000 508,000 635,000 788,000 709,000 --
Cash Cash Equivalents And Short Term Investments 1.1M 1.1M 1.4M 1.4M 1.4M --
Cash Financial 755,000 508,000 635,000 788,000 709,000 --
Other Short Term Investments 325,000 639,000 750,000 636,000 664,000 --
Accounts Receivable 15,000 16,000 12,000 19,000 26,000 --
Receivables 15,000 16,000 12,000 19,000 26,000 --
Current Assets 1.1M 1.2M 1.4M 1.4M 1.4M --
Net PPE 5.9M 5.7M 5.6M 5.6M 5.6M --
Other Non Current Assets 401,000 406,000 350,000 350,000 329,000 --
Total Non Current Assets 6.3M 6.1M 6.0M 6.0M 5.9M --
Total Assets 7.4M 7.3M 7.4M 7.4M 7.3M --
Accounts Payable 9,000 21,000 20,000 37,000 -- --
Payables 9,000 21,000 20,000 37,000 -- --
Payables And Accrued Expenses 9,000 21,000 20,000 62,000 35,000 --
Current Accrued Expenses 0.00 0.00 0.00 25,000 -- --
Current Liabilities 9,000 21,000 20,000 62,000 35,000 --
Total Non Current Liabilities Net Minority Interest 326,000 330,000 337,000 337,000 316,000 --
Total Liabilities Net Minority Interest 335,000 351,000 357,000 399,000 351,000 --
Common Stock 13.5M 13.5M 13.5M 13.5M 13.3M --
Capital Stock 13.5M 13.5M 13.5M 13.5M 13.3M --
Additional Paid In Capital 41.5M 41.5M 41.5M 41.5M -- 41.5M
Retained Earnings -50.4M -50.5M -50.4M -50.4M -50.4M --
Gains Losses Not Affecting Retained Earnings -- -- -- -- 44.0M --
Common Stock Equity 7.0M 7.0M 7.0M 7.0M 6.9M --
Stockholders Equity 7.0M 7.0M 7.0M 7.0M 6.9M --
Total Equity Gross Minority Interest 7.0M 7.0M 7.0M 7.0M 6.9M --
Total Capitalization 7.0M 7.0M 7.0M 7.0M 6.9M --
Net Tangible Assets 7.0M 7.0M 7.0M 7.0M 6.9M --
Tangible Book Value 7.0M 7.0M 7.0M 7.0M 6.9M --
Working Capital 1.1M 1.1M 1.4M 1.4M 1.4M --
Invested Capital 7.0M 7.0M 7.0M 7.0M 6.9M --
Share Issued 51.3M 51.3M 51.3M 51.3M 50.9M --
Ordinary Shares Number 51.3M 51.3M 51.3M 51.3M 50.9M --
Long Term Provisions 326,000 330,000 337,000 337,000 316,000 --
Other Equity Interest 2.4M 2.4M 2.3M 2.3M -- 2.4M
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow -94,000 28,000 -148,000 -150,000 -100,000 --
Cash Flow From Continuing Operating Activities -94,000 28,000 -148,000 -150,000 -100,000 --
Stock Based Compensation 23,000 22,000 22,000 -106,000 65,000 --
Change In Working Capital -11,000 -3,000 -35,000 35,000 -36,000 --
Changes In Account Receivables 1,000 -4,000 7,000 -- -2,000 -3,000
Change In Receivables 1,000 -4,000 7,000 7,000 -2,000 --
Change In Payables And Accrued Expense -12,000 1,000 -42,000 28,000 -34,000 --
Capital Expenditure -125,000 -118,000 -5,000 -- -- --
Purchase Of PPE -- -118,000 -5,000 -- -- 0.00
Net PPE Purchase And Sale -- -118,000 -5,000 0.00 0.00 0.00
Purchase Of Investment -- 0.00 0.00 -181,000 0.00 0.00
Sale Of Investment 461,000 -- -- -- -- --
Net Investment Purchase And Sale 461,000 19,000 0.00 46,000 0.00 --
Investing Cash Flow 341,000 -155,000 -5,000 4,000 -223,000 --
Cash Flow From Continuing Investing Activities 341,000 -155,000 -5,000 4,000 -223,000 --
Financing Cash Flow -- -- -- 225,000 0.00 --
Cash Flow From Continuing Financing Activities -- -- -- 225,000 0.00 --
Changes In Cash 247,000 -127,000 -153,000 79,000 -323,000 --
Beginning Cash Position 508,000 635,000 788,000 709,000 1.0M --
End Cash Position 755,000 508,000 635,000 788,000 709,000 --
Free Cash Flow -219,000 -90,000 -153,000 73,000 -323,000 --
Capital Expenditure Reported -- -- -- -- -223,000 0.00
Net Foreign Currency Exchange Gain Loss -4,000 -- -- -1,000 -3,000 3,000
Net Income From Continuing Operations 45,000 -76,000 -21,000 -60,000 -90,000 --
Net Other Investing Changes 5,000 -- -- -- -- --
Operating Gains Losses -4,000 -- -- -- -- --
Proceeds From Stock Option Exercised -- -- -- 225,000 0.00 --
Sale Of PPE -- -- -5,000 0.00 0.00 0.00
Unrealized Gain Loss On Investment Securities -147,000 92,000 -114,000 3,000 -36,000 --
NEWS
Loading news...
TRENDING
Loading...